# Elicio Therapeutics, Inc. (ELTX)

> Healthcare · US · Reports in USD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/ELTX/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2026 | $ 0 | $ -20.04M | $ -19.81M | $ 14.15M | $ 7.94M |
| 2025 | $ 0 | $ -40.52M | $ -37.85M | $ 14.51M | $ 1.64M |
| 2024 | $ 0 | $ -54.55M | $ -39.05M | $ 26.04M | $ -11.31M |
| 2023 | $ 0 | $ -38.05M | $ -35.42M | $ 6.92M | $ 11.37M |
| 2022 | $ 1.84M | $ -39.53M | $ -25.51M | $ 7.48M | $ 8.92M |
| 2021 | $ 33.21M | $ -28.62M | $ -55.37M | $ 4.66M | $ 81.51M |
| 2020 | $ 2.57M | $ -89.04M | $ -21.34M | $ 85.04M | $ -90.45M |
| 2019 | $ 898.4K | $ -20.67M | N/A | $ 10.78M | $ -18.59M |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | 1.78 |
| Liabilities / Eq | 2.95 |
| Current Ratio | 2.77 |

## Other views

- [Metrics](https://sponda.capital/en/ELTX.md)
- [Charts](https://sponda.capital/en/ELTX/charts.md)
- [Compare](https://sponda.capital/en/ELTX/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-30.